Ashfield Capital Partners LLC Increases Stake in UnitedHealth Group Inc (UNH)
Ashfield Capital Partners LLC lifted its stake in shares of UnitedHealth Group Inc (NYSE:UNH) by 0.9% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 47,850 shares of the healthcare conglomerate’s stock after purchasing an additional 447 shares during the period. UnitedHealth Group makes up about 1.3% of Ashfield Capital Partners LLC’s investment portfolio, making the stock its 23rd biggest position. Ashfield Capital Partners LLC’s holdings in UnitedHealth Group were worth $9,371,000 as of its most recent filing with the Securities and Exchange Commission.
Other hedge funds also recently made changes to their positions in the company. Marshall Wace LLP lifted its holdings in UnitedHealth Group by 441.4% in the second quarter. Marshall Wace LLP now owns 13,935 shares of the healthcare conglomerate’s stock valued at $2,578,000 after buying an additional 11,361 shares during the period. American Century Companies Inc. lifted its holdings in UnitedHealth Group by 16.9% in the second quarter. American Century Companies Inc. now owns 4,703,113 shares of the healthcare conglomerate’s stock valued at $872,051,000 after buying an additional 681,111 shares during the period. Schwab Charles Investment Management Inc. lifted its holdings in UnitedHealth Group by 5.3% in the second quarter. Schwab Charles Investment Management Inc. now owns 3,656,975 shares of the healthcare conglomerate’s stock valued at $678,077,000 after buying an additional 183,401 shares during the period. Essex Financial Services Inc. lifted its holdings in UnitedHealth Group by 12.3% in the second quarter. Essex Financial Services Inc. now owns 8,846 shares of the healthcare conglomerate’s stock valued at $1,640,000 after buying an additional 967 shares during the period. Finally, Bainco International Investors lifted its holdings in UnitedHealth Group by 5.4% in the third quarter. Bainco International Investors now owns 82,676 shares of the healthcare conglomerate’s stock valued at $16,192,000 after buying an additional 4,202 shares during the period. Institutional investors own 86.09% of the company’s stock.
Shares of UnitedHealth Group Inc (NYSE UNH) opened at $232.90 on Wednesday. The company has a quick ratio of 0.70, a current ratio of 0.70 and a debt-to-equity ratio of 0.52. UnitedHealth Group Inc has a 12 month low of $156.09 and a 12 month high of $235.00. The company has a market cap of $225,180.00, a P/E ratio of 26.47, a price-to-earnings-growth ratio of 1.54 and a beta of 0.66.
UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings data on Tuesday, January 16th. The healthcare conglomerate reported $2.59 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $2.50 by $0.09. UnitedHealth Group had a net margin of 4.50% and a return on equity of 21.52%. The company had revenue of $52.06 billion during the quarter, compared to the consensus estimate of $51.57 billion. During the same quarter in the prior year, the firm earned $2.11 earnings per share. The firm’s revenue was up 9.5% compared to the same quarter last year. equities research analysts forecast that UnitedHealth Group Inc will post 9.99 EPS for the current fiscal year.
In other news, Director Kenneth Irwin Shine sold 457 shares of the stock in a transaction on Tuesday, November 14th. The shares were sold at an average price of $211.03, for a total transaction of $96,440.71. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, Director Gail R. Wilensky sold 5,600 shares of the stock in a transaction on Wednesday, November 29th. The stock was sold at an average price of $223.31, for a total transaction of $1,250,536.00. Following the sale, the director now directly owns 61,137 shares of the company’s stock, valued at approximately $13,652,503.47. The disclosure for this sale can be found here. Insiders have sold 34,630 shares of company stock valued at $7,669,416 in the last three months. 0.89% of the stock is owned by insiders.
Several equities analysts recently weighed in on UNH shares. Zacks Investment Research upgraded shares of UnitedHealth Group from a “hold” rating to a “buy” rating and set a $219.00 price objective on the stock in a report on Thursday, September 21st. ValuEngine lowered shares of UnitedHealth Group from a “buy” rating to a “hold” rating in a report on Thursday, October 5th. Sanford C. Bernstein restated an “outperform” rating and issued a $210.00 price objective on shares of UnitedHealth Group in a report on Tuesday, October 10th. Jefferies Group increased their price objective on shares of UnitedHealth Group from $215.00 to $225.00 and gave the company a “buy” rating in a report on Friday, October 13th. Finally, BMO Capital Markets assumed coverage on shares of UnitedHealth Group in a report on Monday, October 16th. They issued an “outperform” rating and a $250.00 price objective on the stock. Three research analysts have rated the stock with a hold rating and twenty-five have given a buy rating to the company. UnitedHealth Group currently has an average rating of “Buy” and a consensus target price of $230.22.
UnitedHealth Group Company Profile
UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Inc (NYSE:UNH).
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.